GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $70,535,000 | -6.5% | 1,620,383 | -6.5% | 1.47% | -5.0% |
| Q1 2022 | $75,471,000 | +4.4% | 1,732,565 | +5.7% | 1.55% | +8.5% |
| Q4 2021 | $72,305,000 | +10.2% | 1,639,565 | -4.5% | 1.43% | +7.8% |
| Q3 2021 | $65,628,000 | -1.2% | 1,717,565 | +3.0% | 1.32% | +4.5% |
| Q2 2021 | $66,402,000 | +6.6% | 1,667,565 | 0.0% | 1.27% | -4.8% |
| Q1 2021 | $62,267,000 | +21.7% | 1,667,565 | +20.0% | 1.33% | +5.4% |
| Q4 2020 | $51,152,000 | +27.9% | 1,390,009 | +16.2% | 1.26% | -8.7% |
| Q3 2020 | $39,990,000 | -17.5% | 1,196,580 | +0.6% | 1.38% | -20.3% |
| Q2 2020 | $48,502,000 | +8.5% | 1,189,059 | +0.8% | 1.74% | +11.2% |
| Q1 2020 | $44,703,000 | -21.2% | 1,179,806 | -2.2% | 1.56% | +4.8% |
| Q4 2019 | $56,708,000 | +10.1% | 1,206,806 | 0.0% | 1.49% | -10.2% |
| Q3 2019 | $51,506,000 | +6.6% | 1,206,806 | 0.0% | 1.66% | +7.7% |
| Q2 2019 | $48,296,000 | -4.2% | 1,206,806 | 0.0% | 1.54% | -3.1% |
| Q1 2019 | $50,432,000 | +8.6% | 1,206,806 | -0.7% | 1.59% | -6.6% |
| Q4 2018 | $46,418,000 | -4.9% | 1,214,806 | 0.0% | 1.70% | +11.4% |
| Q3 2018 | $48,799,000 | -0.3% | 1,214,806 | 0.0% | 1.53% | +6.9% |
| Q2 2018 | $48,969,000 | +0.5% | 1,214,806 | 0.0% | 1.43% | +7.8% |
| Q1 2018 | $48,726,000 | +11.9% | 1,214,806 | -1.1% | 1.33% | +25.2% |
| Q4 2017 | $43,550,000 | -12.6% | 1,227,806 | 0.0% | 1.06% | -16.1% |
| Q3 2017 | $49,849,000 | -5.8% | 1,227,806 | 0.0% | 1.26% | -16.5% |
| Q2 2017 | $52,943,000 | +10.2% | 1,227,806 | +7.7% | 1.51% | +12.0% |
| Q1 2017 | $48,054,000 | +56.2% | 1,139,806 | +42.7% | 1.35% | +52.1% |
| Q4 2016 | $30,762,000 | -10.7% | 798,806 | 0.0% | 0.89% | +5.5% |
| Q3 2016 | $34,453,000 | -0.5% | 798,806 | 0.0% | 0.84% | +3.1% |
| Q2 2016 | $34,620,000 | +6.9% | 798,806 | 0.0% | 0.82% | +13.8% |
| Q1 2016 | $32,392,000 | +0.5% | 798,806 | 0.0% | 0.72% | +1.4% |
| Q4 2015 | $32,232,000 | +4.9% | 798,806 | 0.0% | 0.71% | +8.9% |
| Q3 2015 | $30,714,000 | -7.7% | 798,806 | 0.0% | 0.65% | +15.4% |
| Q2 2015 | $33,270,000 | -9.7% | 798,806 | +0.1% | 0.56% | -6.2% |
| Q1 2015 | $36,828,000 | +7.3% | 798,000 | -0.6% | 0.60% | +8.7% |
| Q4 2014 | $34,320,000 | -7.0% | 803,000 | 0.0% | 0.55% | +7.8% |
| Q3 2014 | $36,914,000 | -5.3% | 803,000 | +10.2% | 0.51% | -6.2% |
| Q2 2014 | $38,987,000 | +0.1% | 729,000 | 0.0% | 0.55% | -4.4% |
| Q1 2014 | $38,950,000 | +0.1% | 729,000 | 0.0% | 0.57% | +5.0% |
| Q4 2013 | $38,921,000 | +16.5% | 729,000 | +9.5% | 0.54% | +10.5% |
| Q3 2013 | $33,413,000 | +0.4% | 666,000 | 0.0% | 0.49% | -2.8% |
| Q2 2013 | $33,280,000 | – | 666,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |